IQV240517P170000
- 3.80
- 0.000.00%
IQVIA Holdings Newsroom
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
IQVIA Holdings' (NYSE:IQV) 12% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. But IQVIA Holdings Inc. (NYSE:IQV)
At US$234, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?
IQVIA Holdings Announces Executive Team Reshuffle and Role Change
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Stifel Nicolaus Keeps Their Buy Rating on IQVIA Holdings (IQV)
Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294
IQVIA Holdings (IQV) has an average rating of outperform and price targets ranging from $245 to $295, according to analysts polled by Capital IQ. Price: 224.25, Change: -2.79, Percent Change: -1.23
IQVIA Holdings Inc. (NYSE:IQV) Q1 2024 Earnings Call Transcript
IQVIA Holdings Price Target Cut to $250.00/Share From $275.00 by Evercore ISI Group
IQVIA Holdings Price Target Cut to $250.00/Share From $275.00 by Evercore ISI Group
Here's Why IQVIA Holdings (IQV) Is a Strong Value Stock
Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs
Across the recent three months, 8 analysts have shared their insights on IQVIA Hldgs (NYSE:IQV), expressing a variety of opinions spanning from bullish to bearish.The table below summarizes their rece
Buy Rating Affirmed for IQVIA Holdings Amidst Strong Growth and Resilient Demand
Leerink Partners Adjusts Price Target on IQVIA to $278 From $290
IQVIA Holdings (IQV) has an average rating of outperform and price targets ranging from $250 to $300, according to analysts polled by Capital IQ.
IQVIA Holdings (IQV) Receives a Buy From Truist Financial
IQVIA Holdings Is Maintained at Neutral by Baird
IQVIA Holdings Is Maintained at Neutral by Baird
Express News | Baird Maintains Neutral on IQVIA Hldgs, Lowers Price Target to $245
IQVIA Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 10.29% Baird $254 → $245 Maintains Neutral 02/27/2024 33.7% Truist Securities $286 → $297 Maint
Express News | IQVIA Holdings Inc : Evercore ISI Cuts Target Price to $250.00 From $275.00
IQVIA Holdings Inc (IQV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...